Perspective Therapeutics, Inc. 8-K

What Happened

• On May 11, 2026, Perspective Therapeutics, Inc. (CATX) filed a Current Report on Form 8-K (Item 2.02) furnishing a press release that announces the company's financial results for the quarter ended March 31, 2026 and recent business highlights.
• The company also posted an updated corporate presentation on its website the same day (reported under Item 8.01). The press release is filed as Exhibit 99.1 and the presentation as Exhibit 99.2 to the Form 8-K.

Key Details

• Filing date: May 11, 2026; quarter covered: quarter ended March 31, 2026.
• Press release announcing quarterly results: Exhibit 99.1 to the 8-K.
• Updated corporate presentation posted at www.perspectivetherapeutics.com and filed as Exhibit 99.2.
• Report signed by Joel Sendek, Chief Financial Officer.

Why It Matters

• The 8-K signals that Perspective has released its latest quarterly earnings and business updates; investors should review the press release and presentation for specifics on revenue, expenses, cash position, clinical or commercial milestones, and any forward-looking commentary.
• Updated corporate materials can contain refreshed guidance, program status, or strategic priorities that may affect investor sentiment and the stock's near-term outlook.